Scopus Biopharma Inc (SCPS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Operating Expenses | 2,929 | 2,680 | 1,836 | 1,899 | 3,320 |
| Operating Income | -2,929 | -2,680 | -1,836 | -1,899 | -3,320 |
| Pre-tax Income | -2,929 | -2,680 | -1,836 | -1,899 | -3,320 |
| Net Income Continuous | -2,929 | -2,680 | -1,836 | -1,899 | -3,320 |
| Minority Interests | -312 | -230 | N/A | N/A | N/A |
| Net Income | $-2,617 | $-2,450 | $-1,731 | $-1,899 | $-3,320 |
| EPS Basic Total Ops | -0.07 | -0.08 | -0.08 | -0.09 | -0.16 |
| EPS Basic Continuous Ops | -0.07 | -0.09 | -0.09 | -0.09 | -0.16 |
| EPS Diluted Total Ops | -0.07 | -0.08 | -0.08 | -0.09 | -0.16 |
| EPS Diluted Continuous Ops | -0.07 | -0.09 | -0.09 | -0.09 | -0.16 |
| EBITDA(a) | $-2,929 | $-2,679 | $-1,836 | $-1,898 | $-3,319 |